Downregulation of chemokine (C‑C motif) ligand 5 induced by a novel 8‑hydroxyquinoline derivative (91b1) suppresses tumor invasiveness in esophageal carcinoma.
Humans
Esophageal Neoplasms
/ drug therapy
Cell Line, Tumor
Chemokine CCL5
/ metabolism
Down-Regulation
/ drug effects
Gene Expression Regulation, Neoplastic
/ drug effects
Neoplasm Invasiveness
Oxyquinoline
/ pharmacology
Antineoplastic Agents
/ pharmacology
Esophageal Squamous Cell Carcinoma
/ drug therapy
Cell Proliferation
/ drug effects
Male
Female
Cell Movement
/ drug effects
Cisplatin
/ pharmacology
Carcinoma, Squamous Cell
/ drug therapy
chemokine (C‑C motif) ligand 5
esophageal squamous cell carcinoma
quinoline derivatives
Journal
International journal of molecular medicine
ISSN: 1791-244X
Titre abrégé: Int J Mol Med
Pays: Greece
ID NLM: 9810955
Informations de publication
Date de publication:
Dec 2024
Dec 2024
Historique:
received:
05
04
2024
accepted:
06
08
2024
medline:
4
10
2024
pubmed:
4
10
2024
entrez:
4
10
2024
Statut:
ppublish
Résumé
Esophageal squamous cell carcinoma (ESCC) is a particularly aggressive form of cancer with high mortality. In the present study, a novel 8‑hydroxyquinoline derivative (91b1) was investigated for its anticancer activities in ESCC along with its associated mechanisms. The
Identifiants
pubmed: 39364750
doi: 10.3892/ijmm.2024.5435
pii: 111
doi:
pii:
Substances chimiques
Chemokine CCL5
0
Oxyquinoline
5UTX5635HP
Antineoplastic Agents
0
CCL5 protein, human
0
Cisplatin
Q20Q21Q62J
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM